Stockscreener 앱 받기
5.73
12.35%
0.63
시간 외 거래:
5.77
0.04
+0.70%
전일 마감가:
$5.10
열려 있는:
$5.01
하루 거래량:
673.70K
Relative Volume:
0.82
시가총액:
$3.17M
수익:
$29.78M
순이익/손실:
$-39.94M
주가수익비율:
-0.0925
EPS:
-61.9139
순현금흐름:
$-16.12M
1주 성능:
-9.76%
1개월 성능:
+15.76%
6개월 성능:
-94.95%
1년 성능:
-98.45%
1일 변동 폭
$5.00
$6.127
1주일 범위
$5.00
$9.42
52주 변동 폭
$3.90
$581.85
22nd Century Group, Inc. Stock (XXII) Company Profile
명칭
22nd Century Group, Inc.
전화
716-270-1523
주소
8560 Main Street, Williamsville, NY
XXII을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
5.73 | 3.17M | 29.78M | -39.94M | -16.12M | -61.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-07-21 | 개시 | Alliance Global Partners | Buy |
| 2022-06-15 | 개시 | Craig Hallum | Buy |
| 2022-03-08 | 개시 | ROTH Capital | Buy |
| 2021-07-23 | 개시 | Cowen | Outperform |
| 2017-10-16 | 재확인 | Chardan Capital Markets | Buy |
| 2016-08-11 | 재확인 | Chardan Capital Markets | Buy |
모두보기
22nd Century Group, Inc. 주식(XXII)의 최신 뉴스
22nd Century Group (NASDAQ: XXII) and Smoker Friendly Forge New Agreement – Market - HPBL
22nd Century Group Announces Strategic Agreement with Smoker Friendly – Market - HPBL
FDA Publishes Proposed New Tobacco Product Standard for Nicotine Yield, Citing VLN from 22nd Century as the Only Combustible Cigarette That Complies with the New Standard - The Manila Times
22nd Century Group's VLN Cigarettes Already Meet FDA's Proposed Nicotine Reduction Standard - StockTitan
Washington Post Story Featuring 22nd Century VLN Products Highlights Proposed FDA Reduced Nicotine Content Policy Could Initially Benefit An Estimated 13 Million Smokers - The Manila Times
22nd Century's VLN Cigarettes Take Spotlight as FDA's Nicotine Reduction Plan Advances - StockTitan
22nd Century Group Stock Rises On Proposed FDA Mandate On Nicotine Content: Retail's Extremely Bullish - MSN
22nd Century Group resets debt conversion price By Investing.com - Investing.com Canada
22nd Century Group resets debt conversion price - Investing.com
XXII22nd Century Group Inc. Latest Stock News & Market Updates - StockTitan
22nd Century ready to support FDA's reduced nicotine cigarette policy, stock up 30% - Seeking Alpha
22nd Century Stands Ready to Support the Adoption of FDA Proposed Tobacco Product Standard to Mandate Reduced Nicotine Content in Cigarettes with its VLN Cigarettes - The Manila Times
22nd Century Group Ready to Lead FDA's Reduced Nicotine Cigarette Revolution with VLN Brand - StockTitan
22nd Century Group (NASDAQ:XXII) Stock Quotes, Forecast and News Summary - Benzinga
Nasdaq Down Over 2%; Walgreens Posts Upbeat Results - Benzinga
Dow Dips 500 Points; US Economy Adds 256,000 Jobs In December - Benzinga
22nd Century Group Completes New Agreement With Smoker Friendly - CSPDailyNews.com
22nd Century & Smoker Friendly Expand Partnership - Tobacco Reporter
Royal Caribbean Cruises Ltd (RCL-N) QuotePress Release - The Globe and Mail
22nd Century Expands Market Reach with New Agreement - TipRanks
22nd Century Group, Inc. Signs New, Expanded License and Manufacturing Agreement with Smoker Friendly International, LLC - Marketscreener.com
22nd Century Group signs expanded license and manufacturing agreement with Smoker Friendly - MSN
22nd Century Group Signs New, Expanded License and Manufacturing Agreement with Smoker Friendly - The Manila Times
22nd Century Group Expands Smoker Friendly Partnership with Premium Brand Launch, 5-Year Deal - StockTitan
StockNews.com Begins Coverage on 22nd Century Group (NASDAQ:XXII) - MarketBeat
22nd Century Group announces reverse stock split By Investing.com - Investing.com Nigeria
22nd Century Group announces reverse stock split - Investing.com
22nd Century : Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of Directors - Marketscreener.com
22Nd Century Group Expands VLN Tobacco Growing Program to Support Anticipated Demand of the Company’S Reduced Nicotine Content Cigarettes - Marketscreener.com
22nd Century Group, Inc. Announces Chief Financial Officer Changes - Marketscreener.com
XXII Stock Plummets to 52-Week Low of $0.04 Amid Market Turbulence By Investing.com - Investing.com South Africa
22nd Century : Reduces Debt by Additional $1.5 Million via Payment from GVB Form 8 K - Marketscreener.com
XXII Stock Plummets to 52-Week Low of $0.04 Amid Market Turbulence - Investing.com
22nd Century Group, Inc. announced that it expects to receive $1.6815 million in funding - Marketscreener.com
Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet - Benzinga
US Stocks Mixed; Broadcom Shares Surge On Upbeat Earnings - Benzinga
22nd Century Group to execute 1-for-135 reverse stock split - MSN
22nd Century Announces 1-for-135 Reverse Stock Split - Yahoo Finance
22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in Cigarettes - The Kingston Whig-Standard
Toll Brothers Inc (TOL-N) QuotePress Release - The Globe and Mail
22nd Century Group approves reverse stock split By Investing.com - Investing.com Nigeria
22nd Century Group approves reverse stock split - Investing.com India
12 Cannabis Stocks to Buy Now in 2024 - MarketBeat
22nd Century Group (XXII) Signs Large New CMO Customer - Newsfile
XXII stock plunges to 52-week low, touches $0.08 - Investing.com
22nd Century Net Loss Widens - Tobacco Reporter
22nd Century: Q3 Earnings Snapshot - CT Insider
XXII stock plunges to 52-week low of $0.09 amid market challenges - Investing.com
22nd Century Group Inc (XXII) Q3 2024 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance
22nd Century Group Faces Ongoing Financial Challenges - TipRanks
22nd Century Group, Inc. (XXII) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.81%
자본화:
|
볼륨(24시간):